Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells
- PMID: 2824563
- PMCID: PMC442414
- DOI: 10.1172/JCI113236
Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells
Abstract
Basic fibroblast growth factor (bFGF) stimulates the proliferation of many cells and it is found in a wide variety of normal or transformed tissues. As demonstrated here, bFGF is also present in cultured human Ewing's sarcoma cells. Unexpectedly, however, bFGF isolated from these cells inhibits their own proliferation, indicating that bFGF can act as an endogenous (autocrine) growth inhibitor for cultured Ewing's sarcoma cells. Since bFGF also inhibits the proliferation of some further tumor cells, but stimulates that of others, it can be considered a bifunctional regulator of tumor cell proliferation. The autocrine growth-inhibitory effect of bFGF in Ewing's sarcoma cells may explain the low mitotic activity of Ewing's sarcomas.
Similar articles
-
Induction of cell death by basic fibroblast growth factor in Ewing's sarcoma.Cancer Res. 2000 Nov 1;60(21):6160-70. Cancer Res. 2000. PMID: 11085540
-
A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.Oncogene. 2000 Aug 31;19(37):4298-301. doi: 10.1038/sj.onc.1203755. Oncogene. 2000. PMID: 10980604
-
Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line.Cancer Res. 1990 Apr 15;50(8):2524-9. Cancer Res. 1990. PMID: 2156622
-
Primary Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) of the penis: a report of an extraordinarily unusual site and a literature review of extraskeletal Ewing's sarcoma.Int J Surg Pathol. 2013 Feb;21(1):63-7. doi: 10.1177/1066896912454565. Epub 2012 Jul 25. Int J Surg Pathol. 2013. PMID: 22832112 Review.
-
Neuropeptide Y in neural crest-derived tumors: effect on growth and vascularization.Cancer Lett. 2007 Jan 8;245(1-2):293-302. doi: 10.1016/j.canlet.2006.01.010. Epub 2006 Mar 2. Cancer Lett. 2007. PMID: 16513255 Review.
Cited by
-
Patient-derived tumoroids from CIC::DUX4 rearranged sarcoma identify MCL1 as a therapeutic target.Nat Commun. 2025 Aug 21;16(1):7688. doi: 10.1038/s41467-025-62629-6. Nat Commun. 2025. PMID: 40841513 Free PMC article.
-
Expression of estrogen receptor α and growth factors in human prolactinoma and its correlation with clinical features and gender.J Endocrinol Invest. 2012 Feb;35(2):174-80. doi: 10.3275/7607. Epub 2011 Mar 21. J Endocrinol Invest. 2012. PMID: 21422801
-
Fibroblast Growth Factor 2 lethally sensitizes cancer cells to stress-targeted therapeutic inhibitors.Mol Oncol. 2019 Feb;13(2):290-306. doi: 10.1002/1878-0261.12402. Epub 2018 Dec 3. Mol Oncol. 2019. PMID: 30422399 Free PMC article.
-
Antiangiogenesis as a novel therapeutic concept in pediatric oncology.J Mol Med (Berl). 1995 Oct;73(10):497-508. doi: 10.1007/BF00198901. J Mol Med (Berl). 1995. PMID: 8581511 Review. No abstract available.
-
PI3K/AKT is involved in mediating survival signals that rescue Ewing tumour cells from fibroblast growth factor 2-induced cell death.Br J Cancer. 2005 Feb 28;92(4):705-10. doi: 10.1038/sj.bjc.6602384. Br J Cancer. 2005. PMID: 15685229 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials